We describe the creation of a mass spectral library of acylcarnitines and conjugated acylcarnitines from the LC-MS/MS analysis of six NIST urine reference materials. To recognize acylcarnitines, we conducted in-depth analyses of fragmentation patterns of acylcarnitines and developed a set of rules, derived from spectra in the NIST17 Tandem MS Library and those identified in urine, using the newly developed hybrid search method. Acylcarnitine tandem spectra were annotated with fragments from carnitine and acyl moieties as well as neutral loss peaks from precursors. Consensus spectra were derived from spectra having similar retention time, fragmentation pattern, and the same precursor m/z and collision energy. The library contains 157 different precursor masses, 586 unique acylcarnitines, and 4 332 acylcarnitine consensus spectra. Furthermore, from spectra that partially satisfied the fragmentation rules of acylcarnitines, we identified 125 conjugated acylcarnitines represented by 987 consensus spectra, which appear to originate from Phase II biotransformation reactions. To our knowledge, this is the first report of conjugated acylcarnitines. The mass spectra provided by this work may be useful for clinical screening of acylcarnitines as well as for studying relationships among fragmentation patterns, collision energies, structures, and retention times of acylcarnitines. Further, these methods are extensible to other classes of metabolites.
We describe the creation of a mass spectral library of n class="Chemical">acylcarnitines anpan>d pan> class="Chemical">conjugated acylcarnitines from the LC-MS/MS analysis of six NIST urine reference materials. To recognize acylcarnitines, we conducted in-depth analyses of fragmentation patterns of acylcarnitines and developed a set of rules, derived from spectra in the NIST17 Tandem MS Library and those identified in urine, using the newly developed hybrid search method. Acylcarnitine tandem spectra were annotated with fragments from carnitine and acyl moieties as well as neutral loss peaks from precursors. Consensus spectra were derived from spectra having similar retention time, fragmentation pattern, and the same precursor m/z and collision energy. The library contains 157 different precursor masses, 586 unique acylcarnitines, and 4 332 acylcarnitineconsensus spectra. Furthermore, from spectra that partially satisfied the fragmentation rules of acylcarnitines, we identified 125 conjugated acylcarnitines represented by 987 consensus spectra, which appear to originate from Phase II biotransformation reactions. To our knowledge, this is the first report of conjugated acylcarnitines. The mass spectra provided by this work may be useful for clinical screening of acylcarnitines as well as for studying relationships among fragmentation patterns, collision energies, structures, and retention times of acylcarnitines. Further, these methods are extensible to other classes of metabolites.
Authors: Arun S Moorthy; William E Wallace; Anthony J Kearsley; Dmitrii V Tchekhovskoi; Stephen E Stein Journal: Anal Chem Date: 2017-12-01 Impact factor: 6.986
Authors: Paul E Minkler; Maria S K Stoll; Stephen T Ingalls; Janos Kerner; Charles L Hoppel Journal: Mol Genet Metab Date: 2015-10-08 Impact factor: 4.797
Authors: Qian Dong; Yuxue Liang; Xinjian Yan; Sanford P Markey; Yuri A Mirokhin; Dmitrii V Tchekhovskoi; Tallat H Bukhari; Stephen E Stein Journal: MAbs Date: 2018-03-06 Impact factor: 5.857
Authors: Evan L Pannkuk; Evagelia C Laiakis; Jerry Angdisen; Meth M Jayatilake; Pelagie Ake; Lorreta Yun-Tien Lin; Heng-Hong Li; Albert J Fornace Journal: Radiat Res Date: 2022-06-01 Impact factor: 3.372
Authors: Qian Dong; Xinjian Yan; Yuxue Liang; Sanford P Markey; Sergey L Sheetlin; Concepcion A Remoroza; William E Wallace; Stephen E Stein Journal: J Proteome Res Date: 2021-02-08 Impact factor: 5.370